The Hipra laboratories hope to market the Spanish vaccine against COVID that they produce at their headquarters in Amer (Girona) as soon as next June, once they complete the last phase of the study, submit the documentation and receive authorization from the European Medicines Agency.
The director of the company’s Human Health division, Carles Fàbrega, told EFE that the forecast is to send all the information on the first Spanish vaccine to the European Medicines Agency in April, to receive a response in May or early June. So the marketing deadline for the second quarter given in January by the Minister of Science, Diana Morant, would be rushed.
Once the green light from Europe arrives, Hipra will enter the industrial manufacturing phase of the vaccine, which would last just over two weeks, after months of preparing the antigen.